脳腫瘍の病態解析
当教室が専門とする脳腫瘍病理診断にフィードバックするため、悪性グリオーマや悪性髄膜腫について幹細胞、治療法、発生メカニズムなど様々な角度から研究を行っています。
- Tabu, K., Kimura, T., Sasai, K., Wang, L., Bizen, N., Nishihara, H., Taga, T., Tanaka, S. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Mol. Cancer, 9, 39, 2010. (IF=5.130)
- Kanno, H., Nishihara, H., Wang, L., Yuzawa, S., Kobayashi, H., Tsuda, M., Kimura, .T, Tanino, M., Terasaka S., and Tanaka, S. Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma. Neuro Oncol., 15, 853-864, 2013. (IF=6.180)
- Kohsaka, S., Takahashi, K., Wang, L., Tanino, M., Kimura, T., Nishihara, H., and Tanaka, S. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma. Cancer Lett., 331, 68-75, 2013.
- Kato, Y., Nishihara, H., Yuzawa, S., Mohri, H., Kanno, H., Hatanaka, Y., Kimura, T., Tanino, M., and Tanaka, S. Immunohistochemical molecular expression profile of metastatic brain tumor for potent personalized medicine. Brain Tumor Pathol., 30, 167-174, 2013.
- Kohsaka, S. and Tanaka, S. Chemotherapeutic Agent for Glioma. “Clinical management and evolving novel therapeutic strategies for patients with brain tumors” INTECH 2013.
- Mahabir, R., Tanino, M., Elmansuri, A., Wang, L., Kimura, T., Itoh, T., Ohba, Y., Nishihara, H., Shirato, H., Tsuda, M., Tanaka, S. Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.
Neuro Oncol. 5, 671-685, 2014. - Kohsaka, S., Hinohara, K., Wang, L., Nishimura, T., Urushido, M., Yachi, K., Tsuda, M., Tanino, M., Kimura, T., Nishihara, H., Gotoh, N., Tanaka, S. Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma.
Neuro Oncol., 16, 960-970, 2014 - Miyazaki, M., Nishihara, H., Terasaka, S., Kobayashi, H., Yamaguchi, S., Ito, T., Kamoshima, Y., Fujimoto, S., Kaneko, S., Katoh, M., Ishii, N., Mohri, H., Tanino, M., Kimura, T., Tanaka, S. Immunohistochemical evaluation of O(6) -methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma.
Neuropathol., 34, 268-276, 2014